The potential of a virus to change DNA and RNA.
Glossary
Oncogenic
02.27.12
-
Breaking News | Clinical Trials
pHOXBIO Unveils Trial Results from COVID Prophylactic Nasal Spray
According to the study, the novel prophylactic nasal spray prevented infection from SARS-CoV-2, the virus that causes COVID-19.
-
Biologics, Proteins, Vaccines | Breaking News | Clinical Trials
Immunic Inc. Signs In-License Agreement with University Medical Center Goettingen, Germany
Covers the combination of DHODH inhibitors and nucleoside analogues to treat viral infections, including Covid-19.
-
Biologics, Proteins, Vaccines | Reader Showcase
Thermo Fisher Launches Gibco AAV Production System
Aims to address the need to make adeno-associated virus (AAV) production more efficient and scalable.
-
Breaking News | Industry News
Lilly’s Antibody Treatment Gets EUA for Post-Exposure COVID Prevention
Phase 3 study shows bamlanivimab 4200 mg reduced the risk of contracting symptomatic COVID-19 by up to 80 percent in nursing home residents.
-
Bio News | Breaking News | Clinical Trial Materials | Collaborations & Alliances | Industry News | Scale-up/Technology Transfer
Tevogen Completes Tech Transfer to CDMO BioCentriq
Reaches commercial manufacturing readiness milestone for its investigational COVID-19 therapy TVGN-489.
